Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Latigo Biotherapeutics Inc | 0 | 7,325,962 | +7,325,962 | $0 | $122.34M | 41.19% | +$122.34M |
| Entrada Therapeutics, Inc.(TRDA) | 4,056,379 | 3,784,650 | -271,729 | $29.85M | $24.03M | 8.09% | -$5.82M |
| Tyra Biosciences, Inc.(TYRA) | 1,029,298 | 1,029,298 | 0 | $32.88M | $22.51M | 7.58% | -$10.37M |
| CAMP4 THERAPEUTICS CORPORATION(CAMP) | 5,869,091 | 5,277,216 | -591,875 | $25.65M | $21.32M | 7.18% | -$4.33M |
| Artiva Biotherapeutics, Inc.(ARTV) | 2,353,304 | 2,353,304 | 0 | $22.83M | $16.76M | 5.64% | -$6.07M |
| Pharvaris N V COM | 797,600 | 479,900 | -317,700 | $27.58M | $15.22M | 5.13% | -$12.36M |
| Tectonic Therapeutic, Inc.(TECX) | 606,660 | 606,660 | 0 | $20.85M | $14.13M | 4.76% | -$6.72M |
| Celldex Therapeutics, Inc.(CLDX) | 497,270 | 422,270 | -75,000 | $18.50M | $13.69M | 4.61% | -$4.82M |
| Zentalis Pharmaceuticals, Inc.(ZNTL) | 3,947,913 | 3,947,913 | 0 | $19.15M | $10.94M | 3.68% | -$8.21M |
| Biohaven Ltd.(BHVN) | 738,972 | 738,972 | 0 | $11.00M | $9.87M | 3.32% | -$1.13M |
| MapLight Therapeutics, Inc.(MPLT) | 950,011 | 741,893 | -208,118 | $34.05M | $7.56M | 2.55% | -$26.49M |
| Silence Therapeutics plcADS(SLN) | 476,200 | 476,200 | 0 | $5.23M | $5.20M | 1.75% | -$23.8K |
| ALX Oncology Holdings Inc.(ALXO) | 3,057,325 | 3,057,325 | 0 | $6.33M | $4.25M | 1.43% | -$2.08M |
| Protara Therapeutics, Inc.(TARA) | 1,369,782 | 1,369,782 | 0 | $5.23M | $4.18M | 1.41% | -$1.05M |
| EyePoint, Inc.(EYPT) | 1,050,000 | 1,050,000 | 0 | $15.02M | $3.43M | 1.16% | -$11.58M |
| Skye Bioscience Inc | 0 | 981,269 | +981,269 | $0 | $1.58M | 0.53% | +$1.58M |
| Skye Bioscience, Inc.(SKYE) | 9,681,763 | 0 | -9,681,763 | $6.71M | $0 | — | -$6.71M |
| Surrozen, Inc.(SRZN) | 271,250 | 0 | -271,250 | $7.04M | $0 | — | -$7.04M |